Colorectal Cancer Clinical Roundup
(ASTRO) Oct 21, 2020 - A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides guidance for physicians who use radiation therapy to treat patients with locally advanced rectal cancer.
(MedTech Dive) Oct 20, 2020 - Under a proposed CMS coverage policy for blood-based screening tests for colorectal cancer, the first such FDA-approved assay sold by Epigenomics failed to meet criteria for Medicare beneficiaries.
(Yahoo! News) Oct 20, 2020 - Changes in patterns of oncology care with the incorporation of immune response in a study of Stage II colon cancer presented at ASCO Quality Care Symposium.
(Medscape Medical News) Oct 14, 2020 - Nearly 3 out of 4 patients with metastatic colorectal cancer (mCRC) experience major financial hardship one year after diagnosis, despite having health insurance coverage.
(Ann Surg) - 2020-10-19
(JAMA Netw Open) - 2020-10-01
(Br J Cancer) - 2020-10-13
(Clin Cancer Res) - 2020-10-12
In the KEYNOTE-177 study, reported at the ESMO 2020 Virtual Meeting, pembrolizumab monotherapy significantly improved progression-free survival (PFS) vs standard chemotherapy as first-line treatment in patients with microsatellite instability-high and/or deficient mismatch repair metastatic colorectal cancer (mCRC).